Mr. John Alan Dulmage is a pharmacist who is specialized in Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist in Nellis Afb, Nevada. Patients can reach him at 4700 Las Vegas Blvd N, Ocallaghan Federal Hospital, Nellis Afb or contact him on 702-653-3212. Active license number of Mr. John Alan Dulmage is 3605 for Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist in North Dakota. Mr. John Alan Dulmage is pharmacist Clinician/Clinical Pharmacy Specialist is a pharmacist with additional training and an expanded scope of practice that may include prescriptive authority, therapeutic management, and disease management.
Complete Profile:
Mr. John Alan Dulmage speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
4700 Las Vegas Blvd N, Ocallaghan Federal Hospital, Nellis Afb, Nevada, 89191-6600
Phone:
702-653-3212
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Mr. John Alan Dulmage are as mentioned below.
NPI Number:
1912090341
NPI Enumeration Date:
30 Sep, 2006
NPI Last Update On:
16 Sep, 2009
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Mr. John Alan Dulmage are as mentioned below.
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1816 Cameron St, Las Vegas, Nevada
Zip:
89102-3513
Phone Number:
702-653-3212
Fax Number:
--
Patients can reach Mr. John Alan Dulmage at 4700 Las Vegas Blvd N, Ocallaghan Federal Hospital, Nellis Afb, Nevada or can call on phone at 702-653-3212.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.